Similar articles

• A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.

  Krolewiecki AJ, Romero HD, Cajal SP, Abraham D, Mimori T, Matsumoto T, Juarez M, Taranto NJ. Krolewiecki AJ, et al. Am J Trop Med Hyg. 2007 Oct;77(4):640-6. Am J Trop Med Hyg. 2007. PMID: 17978064 Clinical Trial.
• Treatment of cutaneous leishmaniasis in travelers 2009.

  Blum JA, Hatz CF. Blum JA, et al. J Travel Med. 2009 Mar-Apr;16(2):123-31. doi: 10.1111/j.1708-8305.2008.00286.x. J Travel Med. 2009. PMID: 19335813 Review. No abstract available.
• Symmetrical cutaneous leishmaniasis.

  Guarneri C, Guarneri F. Guarneri C, et al. Acta Derm Venereol. 2005;85(3):281-2. doi: 10.1080/00015550510026596. Acta Derm Venereol. 2005. PMID: 16040429 No abstract available.
• Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.

  Soto J, Rea J, Balderrama M, Toledo J, Soto P, Valda L, Berman JD. Soto J, et al. Am J Trop Med Hyg. 2008 Feb;78(2):210-1. Am J Trop Med Hyg. 2008. PMID: 18256415 Clinical Trial.
• [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].

  Santos J, Rivero A, Márquez M. Santos J, et al. An Med Interna. 2000 Oct;17(10):562-3. An Med Interna. 2000. PMID: 11109659 Review. Spanish. No abstract available.